KRH, Klinikum Siloah

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• ANCA-associated vasculitis1 trial
• Gastric and oesophageal cancer1 trial
• Irritable bowel syndrome1 trial

Phase

• Phase 41 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial
• REPHA GmbH Biologische Arzneimittel1 trial
• Vifor Fresenius Medical Care Renal Pharma1 trial

Running trials

• Active, not recruiting

  A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)

  NCT05993234· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Active, not recruiting

  Avacostar - (PASS)

  NCT05897684· Vifor Fresenius Medical Care Renal Pharma· Source

• Recruiting

  Controlled clinical trial to investigate the efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhoea-dominant irritable bowel syndrome (IBS-D)

  2024-514383-61-00· Phase 4· REPHA GmbH Biologische Arzneimittel· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Irritable bowel syndrome1 recruiting